Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-71
Closed -$2K 344
2019
Q2
$2K Hold
71
﹤0.01% 322
2019
Q1
$2K Hold
71
﹤0.01% 295
2018
Q4
$2K Sell
71
-65
-48% -$2.25K ﹤0.01% 291
2018
Q3
$3K Hold
136
﹤0.01% 283
2018
Q2
$6K Buy
136
+1
+0.7% +$40 ﹤0.01% 264
2018
Q1
$5K Hold
135
﹤0.01% 278
2017
Q4
$5K Hold
135
﹤0.01% 264
2017
Q3
$5K Hold
135
﹤0.01% 226
2017
Q2
$4K Hold
135
﹤0.01% 240
2017
Q1
$5K Hold
135
﹤0.01% 258
2016
Q4
$5K Buy
135
+1
+0.7% +$36 ﹤0.01% 271
2016
Q3
$5K Hold
134
﹤0.01% 247
2016
Q2
$5K Hold
134
﹤0.01% 213
2016
Q1
$4K Buy
134
+2
+2% +$61 ﹤0.01% 209
2015
Q4
$4K Buy
132
+2
+2% +$74 ﹤0.01% 177
2015
Q3
$5K Buy
130
+1
+0.8% +$41 ﹤0.01% 165
2015
Q2
$6K Sell
129
-633
-83% -$32.5K ﹤0.01% 174
2015
Q1
$38K Buy
+762
New +$41.3K 0.02% 103

Other funds holding NOV

Roble Belko & Company's NOV Position: Q3 2019 in Review

Roble Belko & Company sold out of NOV (NOV) in Q3 2019, closing a stake of 71 shares — an estimated $2K sold.

Roble Belko & Company first reported a position in NOV in Q1 2015 and held it in 18 quarters. The position peaked at $38K in Q1 2015. 482 funds tracked by Wall St. Rank hold NOV as of Q3 2019.

  • Roble Belko & Company reported no remaining NOV position as of Q3 2019 after selling out during the quarter.
  • Roble Belko & Company sold 71 NOV shares in Q3 2019, an estimated $2K.
  • Roble Belko & Company first reported a position in NOV in Q1 2015 and held it in 18 quarters.
  • Roble Belko & Company's NOV position peaked at $38K in Q1 2015.
  • 482 funds tracked by Wall St. Rank held NOV as of Q3 2019.

Based on Roble Belko & Company's 13F filing for Q3 2019, filed 13 Nov 2019.